Review
Open access
Oct 2026
Beyond Single-Target Therapy: Dual-Acting Cannabinoid Type-2 Receptor Modulation in Neurological Disorders.
Advances in the design, synthesis, and structure-activity relationships of CB2R-targeting ligands are summarized, emphasizing dual- or multitarget agents with cholinesterase inhibitory activity.
Sandeep K. Bindra, T. Rangarajan, D. G. T. Parambi et al.
· ChemMedChem · 0 citations